Wealth Enhancement Advisory Services
PRAX icon

Wealth Enhancement Advisory Services’s Praxis Precision Medicines PRAX Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Sell
745
-42
-5% -$13.3K ﹤0.01% 3412
2026
Q1 		$244K Buy
+787
New +$243K ﹤0.01% 2975

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Wealth Enhancement Advisory Services's PRAX Position: Q2 2026 in Review

Wealth Enhancement Advisory Services reduced its Praxis Precision Medicines (PRAX) stake by 5.3% in Q2 2026, selling an estimated $13.3K and leaving 745 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #3412.

Wealth Enhancement Advisory Services first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. The position peaked at $244K in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Wealth Enhancement Advisory Services held 745 shares of Praxis Precision Medicines worth $242K as of Q2 2026.
  • Wealth Enhancement Advisory Services sold 42 Praxis Precision Medicines shares in Q2 2026, an estimated $13.3K.
  • Praxis Precision Medicines made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3412 holding.
  • Wealth Enhancement Advisory Services first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • Wealth Enhancement Advisory Services's Praxis Precision Medicines position peaked at $244K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.